3. EntreMed (ENMD)
Company Profile: EntreMed is a clinical-stage pharmaceutical company working on treatments of cancer and inflammatory diseases.Altman Z-score: -86.84 Current Share Price: $3.80 (June 7) 2011 Return: -27% Current Ratio: 2.90, an indication that EntreMed should be able to meet its short-term liabilities with its current assets.
2. SulphCo (SUF) Company Profile: SulphCo has developed its proprietary Sonocracking technology, which uses ultrasonic sound waves as part of a desulfurization process of crude oil products. Altman Z-score: -115.40 Current Share Price: 6 cents (June 7) 2011 Return: -67% Current Ratio: 0.80, indicating that SulphCo may have trouble meeting its short-term liabilities with its current assets.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV